Inventory adjustments in digital cameras due to delays in customers' new product releases
First written in FY2017-Q1. 8 of 24 entries say "Mitigated", first in FY2019-Q2. Latest entry: FY2026-H1.
The whole theme swung hardest in 2022: 2 of 7 companies on the "Worse" side.
4 other companies' latest entry also says "Mitigated".
- FY2026-H1MitigatedAnnual report
「For image processing and measurement equipment, sales of pathological digital slide scanners used in telepathology increased against a backdrop of solid demand growth in Europe and the United States. In addition, demand recovered for digital cameras used in the life sciences and biotechnology fields, resulting in higher sales.」
For digital cameras previously reported as facing lower demand in the biotechnology and industrial fields, a recovery in demand and increased sales in the life sciences and biotechnology fields are now reported, indicating that weakness in sales has eased. - 2026-05-14MitigatedEarnings forecast revision
「Sales increased as demand recovered for digital cameras used in the life sciences and biotechnology fields.」
Demand for digital cameras, which had previously been reported as declining, recovered in the life sciences and biotechnology fields, resulting in higher sales. - FY2025-H1WorsenedAnnual report
「Demand for digital cameras declined in the biotechnology and industrial fields, resulting in lower sales.」
For digital cameras previously described as increasing or recovering, declines in demand and sales in the biotechnology and industrial fields are now reported. - FY2024-Q1RestatedAnnual report
「Sales of digital cameras also increased in the physical sciences, including quantum and astronomy.」
For digital cameras previously described as declining or weak, increases in the physical sciences, including quantum and astronomy, continue. - FY2023-Q2RestatedAnnual report
「Digital camera sales increased in the physical sciences, including quantum and astronomy, as well as in the life sciences and biotechnology fields, because the cameras can capture low levels of light over a wide field of view with high precision.」
For digital cameras previously described as declining or weak, increases continue in the physical sciences, including quantum and astronomy, as well as in the life sciences and biotechnology fields. - FY2022MitigatedAnnual report
「Digital camera sales increased in the life sciences and biotechnology fields as well as the physical sciences, including quantum and astronomy applications, following the launch of new products, and overseas sales for DNA testing also increased.」
For digital cameras previously described as declining or weak, full-year increases were confirmed in the life sciences and biotechnology fields, quantum and astronomy applications, and overseas DNA testing. - FY2022-Q3RestatedAnnual report
「Digital camera sales increased in the life sciences and biotechnology fields as well as the physical sciences, following the launch of new products, and overseas sales for DNA testing also remained strong.」
For digital cameras previously described as declining or weak, increases or strong performance in the life sciences and biotechnology fields, the physical sciences and overseas DNA testing continue. - FY2022-Q2MitigatedAnnual report
「Digital camera sales increased in the life sciences and biotechnology fields as well as the physical sciences, following the launch of new products, and overseas sales for DNA testing also remained strong.」
For digital cameras previously described as declining or weak, increases or strong performance are now reported in the life sciences and biotechnology fields, the physical sciences and overseas DNA testing, indicating that weakness in sales has eased. - FY2021-Q3RestatedAnnual report
「Sales of board cameras for specimen testing equipment increased in North America.」
For digital camera-related products previously described as declining or sluggish, increased North American sales of board cameras for specimen testing equipment are reported for the second consecutive quarter, indicating that the easing of weakness in sales is continuing. - FY2021-Q2MitigatedAnnual report
「Sales of board cameras for specimen testing equipment increased, mainly in North America.」
For digital camera-related products previously described as declining or sluggish, increased sales of board cameras for specimen testing equipment, mainly in North America, are now reported, indicating that weakness in sales has eased. - FY2021-Q1New disclosure of increased sales of digital cameras for PCR testingAnnual report
「In addition, sales of digital cameras for PCR testing increased, mainly overseas.」
For digital cameras previously described as weak, sales for PCR testing are now reported to have increased, mainly overseas, indicating a change in the demand mix by application. - FY2020WorsenedAnnual report
「Sales of digital cameras used in the life sciences and biotechnology fields declined both in Japan and overseas due to stagnant activity at universities, research institutions and other organizations.」
The full-year disclosure states that sales declined in Japan and overseas due to stagnant activity at universities, research institutions and other organizations, compared with the decline in Europe and the US in the third quarter, indicating that weakness has spread more broadly. - FY2020-Q3The decline in digital camera sales in Europe and the US widenedAnnual report
「Sales of digital cameras used in the life sciences and biotechnology fields declined sharply in Europe and the US.」
Whereas the previous quarter reported strong performance in Japan and the US alongside a decline in Europe, this quarter describes a sharp decline in Europe and the US, indicating broader weakness across regions. - FY2020-Q2Strong performance in Japan and the US alongside a sharp decline in EuropeAnnual report
「Digital cameras used in the life sciences and biotechnology fields performed well in Japan and the US, but sales declined sharply in Europe.」
Instead of the previously reported sales growth centered on Japan, this time strong performance in Japan and the US is reported alongside a sharp decline in Europe, indicating diverging regional sales trends. - FY2020-Q1MitigatedAnnual report
「Sales of digital cameras used in the life sciences and biotechnology fields increased, mainly in Japan.」
Digital cameras for the life sciences and biotechnology fields, previously described as experiencing declines and sluggishness, are now reported to have increased sales, mainly in Japan, indicating that weakness in sales has eased. - FY2019-Q3MitigatedAnnual report
「Demand for digital cameras increased in the life sciences and biotechnology fields as well as the industrial field, helped by the launch of new products, and sales increased.」
For digital cameras for the life sciences and biotechnology fields, where declines and sluggishness had previously continued, demand and sales, including in the industrial field, continue to increase, indicating that weakness has eased. - FY2019-Q2MitigatedAnnual report
「Demand for digital cameras increased in the life sciences and biotechnology fields as well as the industrial field, helped by the launch of new products, and sales increased.」
For digital cameras for the life sciences and biotechnology fields, where declines and sluggishness had previously continued, increased demand and sales, including in the industrial field, are now reported, indicating that weakness in sales has eased. - FY2019-Q1RestatedAnnual report
「Sales of digital cameras used in the life sciences and biotechnology fields declined, mainly in North America.」
The decline in sales of digital cameras for the life sciences and biotechnology fields continued, this time described as being concentrated mainly in North America. - FY2018The customer inventory adjustment shifted from digital cameras to X-ray line-sensor camerasAnnual report
「However, sales of X-ray line-sensor cameras declined due to the impact of customers' inventory adjustments.」
The factor of lower revenue resulting from customers' inventory adjustments continued, but the affected product shifted from the digital cameras for the life sciences and biotechnology fields previously cited to X-ray line-sensor cameras. - FY2018-Q3SoftenedAnnual report
「In addition, sales of digital cameras used in the life sciences and biotechnology fields remained sluggish.」
For digital cameras for the life sciences and biotechnology fields, the wording has changed from “decline” through the previous period to “remained sluggish” this time. They are still not described as performing well. - FY2018-Q2RestatedAnnual report
「In addition, sales of digital cameras used in the life sciences and biotechnology fields also declined.」
Sales of digital cameras for the life sciences and biotechnology fields continue to decline. This time, the decline is stated simply as lower sales rather than being attributed to delays in customers' new product launches. - FY2017-Q3RestatedAnnual report
「Sales of digital cameras used in the life sciences and biotechnology fields declined overseas.」
Overseas sales of digital cameras for the life sciences and biotechnology fields continue to decline. - FY2017-Q2Continued revenue decline, with a change in the stated factorsAnnual report
「However, sales of digital cameras used in the life sciences and biotechnology fields declined overseas.」
Digital camera sales continue to decline, but this time the decline is attributed to lower overseas sales rather than delays in customers' new product launches or inventory adjustments. - FY2017-Q1First statedAnnual report
「Sales of digital cameras used in the life sciences and biotechnology fields declined as a result of inventory adjustments caused by delays in customers' new product launches. As a result, the image measurement equipment business reported net sales of ¥3,806 million, down 0.3% year on year, and operating profit of ¥674 million, down 10.8% year on year.」
It states that delays in customers' new product launches and the resulting inventory adjustments actually materialized as lower digital camera sales and weaker performance in the image measurement equipment business.